ADC Total Current Liabilities from 2010 to 2024
| ADCT Stock | USD 4.78 0.19 3.82% |
Total Current Liabilities | First Reported 2018-12-31 | Previous Quarter 78.2 M | Current Value 67.7 M | Quarterly Volatility 27 M |
Check ADC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ADC main balance sheet or income statement drivers, such as Interest Income of 5 M, Depreciation And Amortization of 7 M or Interest Expense of 55.9 M, as well as many exotic indicators such as Price To Sales Ratio of 1.85, Dividend Yield of 0.0 or Days Sales Outstanding of 126. ADC financial statements analysis is a perfect complement when working with ADC Therapeutics Valuation or Volatility modules.
ADC | Total Current Liabilities |
Latest ADC Therapeutics' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of ADC Therapeutics SA over the last few years. Total Current Liabilities is an item on ADC Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ADC Therapeutics SA are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. ADC Therapeutics' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ADC Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
ADC Total Current Liabilities Regression Statistics
| Arithmetic Mean | 35,218,542 | |
| Geometric Mean | 24,184,933 | |
| Coefficient Of Variation | 87.08 | |
| Mean Deviation | 26,148,650 | |
| Median | 20,547,000 | |
| Standard Deviation | 30,667,738 | |
| Sample Variance | 940.5T | |
| Range | 89.3M | |
| R-Value | 0.82 | |
| Mean Square Error | 325T | |
| R-Squared | 0.68 | |
| Significance | 0.0002 | |
| Slope | 5,651,398 | |
| Total Sum of Squares | 13167.1T |
ADC Total Current Liabilities History
About ADC Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ADC Therapeutics income statement, its balance sheet, and the statement of cash flows. ADC Therapeutics investors use historical funamental indicators, such as ADC Therapeutics's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although ADC Therapeutics investors may use each financial statement separately, they are all related. The changes in ADC Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ADC Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ADC Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ADC Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 77.8 M | 48.6 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADC Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADC Therapeutics' short interest history, or implied volatility extrapolated from ADC Therapeutics options trading.
Pair Trading with ADC Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ADC Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with ADC Stock
| 0.65 | AVNW | Aviat Networks Earnings Call This Week | PairCorr |
Moving against ADC Stock
| 0.81 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.67 | DZSI | DZS Inc Financial Report 13th of May 2024 | PairCorr |
| 0.64 | AAPL | Apple Inc Earnings Call Next Week | PairCorr |
| 0.53 | MX | MagnaChip Semiconductor Earnings Call Next Week | PairCorr |
| 0.51 | INTC | Intel Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to ADC Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ADC Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ADC Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ADC Therapeutics SA to buy it.
The correlation of ADC Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ADC Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ADC Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ADC Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of ADC Therapeutics Correlation against competitors. Note that the ADC Therapeutics information on this page should be used as a complementary analysis to other ADC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for ADC Stock analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is ADC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 0.851 | Quarterly Revenue Growth (0.76) | Return On Assets (0.25) | Return On Equity (7.06) |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.